Firm
Stephen Yang joins us for our ‘Five minutes with’ series to explain why his role requires him to wear many hats
The complaint follows a declaratory ruling issued by the England and Wales High Court last month that said Samsung is entitled to an interim licence
Tobias Hahn explains how the firm's multi-jurisdictional setup enabled it to secure an injunction on behalf of Fujifilm relating to defendant Kodak’s non-UPC activity
Reckitt Benckiser is to divest its Essential Home business, which includes more than 70 brands, to private equity firm Advent International
Sponsored
Sponsored
-
Sponsored by CASBiologics intellectual property is complex and evolving rapidly, which makes effective searches vital. This CAS article presents expert strategies to address search challenges, protect innovations, and build stronger, litigation-ready patent programmes throughout the R&D life cycle -
Sponsored by Remfry & SagarRadha Khera and Sanhita Chatterjee of Remfry & Sagar explore how fashion brands are deploying AI, blockchain, and legal-tech tools to fight the escalating global threat of counterfeiting and protect brand integrity
-
Sponsored by ZaccoJoin Managing IP and Zacco on June 10 to explore why intellectual property due diligence is critical to investment and acquisition success. Learn what to look out for when evaluating an IP portfolio and product roadmap, maximising potential value and mitigating the risk of expensive surprises
-
Sponsored by ZaccoDesign rights are set to play an increasingly important role in strengthening global intellectual property strategies, say Tomas Wässingbo of Zacco and Christina Wainikka of the Confederation of Swedish Enterprise
-
Sponsored by TOPPAN Digital IPChris Evans of TOPPAN Digital IP outlines how AI, structured authoring, and secure technology are reshaping patent translation to improve quality, reduce costs, and accelerate international intellectual property filings in a managed environment
-
Sponsored by Wanhuida Intellectual PropertyHonghui Hu of Wanhuida Intellectual Property examines how the Supreme People’s Court has clarified the patent scope of drug combination inventions in a patent linkage dispute, offering rare guidance on claim interpretation of pharmaceutical combinations
